Global Prostate Cancer Diagnostics Market Overview: Projected to Grow to Nearly US$ 1.1 Bn in 2022

A fresh study, covering “Prostate Cancer Diagnostics Market Forecast, Trend Analysis & Competition Tracking: Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the Healthcare Market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make the research a powerful source for analysts and industry experts who are looking to gain necessary knowledge about the prevailing market trends, opportunities and drivers present in the Prostate Cancer Diagnostics Market.

Request For Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=58

PCA3 and PSA Test Segment Vital in the Prostate Cancer Diagnostics Market

The PCA3 and PSA test segments can be considered the most important in the prostate cancer diagnostics market as they both represent the highest potential in terms of market opportunity. The PSA segment is anticipated to be worth just over US$ 270 million in 2017 and it should grow at a healthy CAGR during the period 2017-2022. On the other hand, the PCA3 segment is poised to grow to nearly US$ 284 million by the end of the forecast period.

North America is the largest region for both segments and accounts for nearly 2/5th of the prostate cancer diagnostics market. The region’s large geriatric population and high prevalence of cancer mean that demand for prostate cancer diagnostics will continue to remain strong during the forecast period.

Smaller Share of CTC

The CTC segment holds revenue share in the global prostate cancer diagnostics market. This segment is projected to reach US$ 141 million by the end of 2022.

The immunohistochemistry segment is projected to witness a CAGR of 4.5% for the five-year study period. While North America may be the largest regional contributor, key stakeholders could also focus on Europe as it holds a revenue share of more than 30% throughout the period.

Focus on Hospital Labs and Research Institutes

The hospital associated labs segment is assessed to grow significantly during the forecast period. It would make sense for companies to focus on cancer research institutes as collaboration can help in the development of innovative solutions. In this case, companies could think of targeting the APEJ region as it has the highest CAGR during the forecast period. The region spends much less on healthcare as a percentage of GDP than the developed world but strong economic growth will all but ensure that it becomes ever-more important to regional governments in future.

Browse Full Report With TOC- https://www.factmr.com/report/58/prostate-cancer-diagnostics-market

Table of Content

Chapter 1. Global Prostate Cancer Diagnostics Market - Executive Summary. 11

Chapter 2. Global Prostate Cancer Diagnostics Market Overview. 13
2.1. Introduction. 13
       2.1.1. Global Prostate Cancer Diagnostics Market Taxonomy. 13
       2.1.2. Global Prostate Cancer Diagnostics Market Definition. 13
2.2. Global Prostate Cancer Diagnostics Market Size (US$ Mn) and Forecast, 2012-2022. 14
       2.2.1. Global Prostate Cancer Diagnostics Market Y-o-Y Growth. 14
2.3. Global Prostate Cancer Diagnostics Market Dynamics. 14
       2.3.1. Drivers. 14
       2.3.2. Restraints. 14
       2.3.3. Trends. 15
2.4. Supply Chain. 15
2.5. Epidemiology. 15
2.6. Key Participants Market Presence (Intensity Map) By Region. 15

Chapter 3. Global Prostate Cancer Diagnostics Market Analysis and Forecast By Test Type. 16
3.1. Global Prostate Cancer Diagnostics Market Size and Forecast By Test Type, 2012-2022. 16
       3.1.1. PSA Tests Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 16
                3.1.1.1. Revenue (US$ Mn) Comparison, By Region. 16
                3.1.1.2. Market Share Comparison, By Region. 18
                3.1.1.3. Y-o-Y growth Comparison, By Region. 18
       3.1.2. CTC Tests Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 19
                3.1.2.1. Revenue (US$ Mn) Comparison, By Region. 19
                3.1.2.2. Market Share Comparison, By Region. 21
                3.1.2.3. Y-o-Y growth Comparison, By Region. 21
       3.1.3. Immunohistochemistry Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 22
                3.1.3.1. Revenue (US$ Mn) Comparison, By Region. 22
                3.1.3.2. Market Share Comparison, By Region. 24
                3.1.3.3. Y-o-Y growth Comparison, By Region. 24
       3.1.4. PCA3 test Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 25
                3.1.4.1. Revenue (US$ Mn) Comparison, By Region. 25
                3.1.4.2. Market Share Comparison, By Region. 27
                3.1.4.3. Y-o-Y growth Comparison, By Region. 27
       3.1.5. Others Prostate Cancer Diagnostics Market Size and Forecast, 2012-2022. 28
                3.1.5.1. Revenue (US$ Mn) Comparison, By Region. 28
                3.1.5.2. Market Share Comparison, By Region. 30
                3.1.5.3. Y-o-Y growth Comparison, By Region. 30

Continue…..

Request For Discount On This Report- https://www.factmr.com/connectus/sample?flag=D&rep_id=58

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Fact.MR
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Telephone: +353-1-6111-593
Email: sales@factmr.com/
Web: https://www.factmr.com/

This release was published on openPR.